Bridgefront Capital, LLC Laboratory Corp Of America Holdings Transaction History

Bridgefront Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$209.01 - $232.56 $979,838 - $1.09 Million	4,688 New	4,688 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $104,057 - $118,493	491 Added 22.28%	2,695 $650,000
Q1 2023 May 15, 2023	BUY	$213.32 - $257.83 $470,157 - $568,257	2,204 New	2,204 $505,000
Q2 2022 Aug 12, 2022	SELL	$213.86 - $277.87 $230,754 - $299,821	-1,079 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$259.82 - $298.18 $55,341 - $63,512	213 Added 24.6%	1,079 $284,000
Q4 2021 Feb 10, 2022	BUY	$271.6 - $314.21 $235,205 - $272,105	866 New	866 $272,000
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $692,699 - $862,256	-3,381 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$186.91 - $214.42 $631,942 - $724,954	3,381 New	3,381 $688,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.